In agreement with our results, it is well known that ILK activation is involved in survival, proliferation, motility, invasion, angiogenesis [34] and that ILK silencing inhibits EMT, cell growth and metastasis in BC cells [35]. This evidence concerns the gene ILK and breast cancer.